医学培训课件 炎症性肠病IBDe 英文版.ppt

上传人:小****库 文档编号:3584557 上传时间:2020-09-21 格式:PPT 页数:32 大小:1.20MB
返回 下载 相关 举报
医学培训课件 炎症性肠病IBDe 英文版.ppt_第1页
第1页 / 共32页
医学培训课件 炎症性肠病IBDe 英文版.ppt_第2页
第2页 / 共32页
亲,该文档总共32页,到这儿已超出免费预览范围,如果喜欢就下载吧!
资源描述

《医学培训课件 炎症性肠病IBDe 英文版.ppt》由会员分享,可在线阅读,更多相关《医学培训课件 炎症性肠病IBDe 英文版.ppt(32页珍藏版)》请在taowenge.com淘文阁网|工程机械CAD图纸|机械工程制图|CAD装配图下载|SolidWorks_CaTia_CAD_UG_PROE_设计图分享下载上搜索。

1、Inflammatory Bowel Disease,Hongyu Ren,MD Division of GI, Xiehe Hospital, Wuhan,Overview,Introduction/Epidemiology Pathogenesis Clinical Manifestations Conventional Therapies Prognosis,Introduction,Definition: Chronic autoimmune inflammatory disorders, involving some or all layers of the gut wall.,Ul

2、cerative Colitis (UC) Mucosal / submucosal only,Crohns Disease (CD) All layers of wall at risk,Ulcerative Colitis,Crohns Disease,Endoscopic Appearance,Normal colon,Friability Exudate bleeding,Diffuse ulceration,Cobblestoning,Focal ulceration,Histology/Depth of IBD,Mucosal and submucosal only No gran

3、ulomas seen,* Transmural disease * Granulomas occasionally seen,Ulcerative Colitis,Crohns Disease,Ulcerative Colitis vs Crohns Disease,Epidemiology,Incidence: 5-29 per 100,000 people per year Prevalence: 1.3 million persons New cases: estimated 20,000-100,000 per year* Gender distribution: Crohns di

4、sease: Slight female predominance Ulcerative Colitis: Slight male predominance Age incidence - Bimodal distribution Peak onset: 15 to 25 years of age Second peak incidence: 50 to 65 years of age,Anti-inflammatory,Pro-inflammatory,TNF IL-1b IL-12 / IL-18 IFNg,IL-4 / IL-13 IL-1Ra TGFb IL-10 PGE2,Patho

5、genesis,Pathogenesis of Inflammatory Bowel Disease,Immune Dysregulation,IBD,GeneticSusceptibility,Environmental Triggers,Environment,Risk factors: Occupations associated with outdoor physical labor Higher socioeconomic status Women who use oral contraceptives Increased intake of refined sugars and a

6、 paucity of fresh fruits and vegetables in the diet Smoking Stress,Risk Factors,Known Family history of IBD Cigarette smoking Risk for CD Protective for UC Appendectomy Risk for CD Protective for UC,Possible Oral contraceptives Diet: sugar, fat Breastfeeding (protective) Childhood infections Measles

7、 infection Mycobacterium paratuberculosis infection,The relative risk among first-degree relatives is 14 to 15 times higher than that of the general population Ethnicity plays a role as well The concordance rate among monozygotic twins is as high as 67% for Crohns disease but only 13% to 20% for ulc

8、erative colitis,Genetics,Genetics,10-25% of patients have a 1st degree relative with IBD Lifetime risk for siblings and offspring of IBD patients: 10% Monozygotic twins often share disease pattern and age of onset Concordance CD (58%) UC (6%) Genome search loci on chromosomes 3, 5, 6, 12, 14, 16, 19

9、,Luminal antigen,Mucosal immune System (APC),Th2,Th1,T-supp/T-reg cells,TNF-, IFN-,IL-4 IL-5 IL-10,Humoral immune response B-cell, plasma cell expansion Increased Ig secretion,Th1 vs Th2 response,Crohns Disease,Cytokine production,Resistance to normal downregulation,Tissue injury Ineffective repair,

10、Ulcerative Colitis,Healthy Colon,Cell-mediated immune response,Immune Dysregulation,Pathology,Macroscopic Features Early lesion-aphthous ulcer Later Findings-Linear or serpiginous ulcers may form in a longitudinal direction. Irregular thickening of the bowel wall and, along with hypertrophy of the m

11、uscularis mucosa. Microscopic level The transmural nature of the inflammation. The presence of granulomas.,Clinical Manifestations,History,Exam,Laboratory,Endoscopy,Stool Studies,Clinical Presentation,Signs Mild or moderate disease usually look well Severe attacks: fever tachycardia abdominal tender

12、ness distension decreased bowel sounds Clubbing,Lab evaluation Acute phase reactants: ESR, CRP elevation Leukocytosis Anemia Reduced serum albumin Hypokalemia Abnormal LFTs Stool: leukocytes, RBCs,Symptoms,Crohns Disease Diarrhea (non-bloody) Weight loss Fever Perianal drainage/pus Right lower quadr

13、ant pain,Ulcerative Colitis Rectal bleeding Fecal urgency / tenesmus Diarrhea (bloody) Lower abdominal cramping,Disease Distribution,Ulcerative Colitis Rectum Cecum Confluent / Contiguous Ileal involvement uncommon No perianal disease,Crohns Disease Anywhere from “mouth to anus” Segmental / Skip Les

14、ions Rectum usually spared Ileal involvement common Perianal disease common,Ulcerative Colitis distribution,Mild,Severe,30%,40%,30%,Crohns Disease distribution,Liver,Eyes,Skin,Joints,Blood,Heart,Mouth,Extraintestinal IBD,Complication-UC,Massive hemorrhage Perforation acute dilatation of the colon (t

15、oxic megacolon) strictures pseudopolyps colonic cancer,Complication-CD,Stricture Fistula and Abscess perforation and bleeding cholelithiasis,Complications of Crohns Disease,Crohns Strictures,Complications of Crohns Disease,Crohns Fistulae,Perianal fistula,Complications of Crohns Disease,Crohns Fistu

16、lae,Entero-enteral fistula,Assessment of Disease Severity,Mildfewer than four stools daily, with or without blood, with no systemic disturbance and a normal erythrocyte sedimentation rate (ESR). Moderatemore than four stools daily but with minimal systemic disturbance. Severemore than six stools dai

17、ly with blood and with evidence of systemic disturbance, as shown by fever, tachycardia, anemia, or an ESR greater than 30.,Treatment Goals,Diagnosis and prompt therapeutic response Induction of complete remission Low side-effect profile to enhance compliance Maintenance of clinical remission Medica

18、l vs. surgical remission Steroid sparing Education and improvement of quality of life,Treatment,Conventional therapies: 5-ASA/SASP Corticosteroids/Budesonide Immunomodulators Antibiotics Anti-metabolites Biologic Modifiers,Prognosis,Ulcerative colitis 80% have intermittent attacks of their disease F

19、rom 10% to 15% of patients pursue a chronic continuous course,Crohn Disease Over a 4-year, 22% of patients remain in remission, 25% experience active symptoms, and 53% between active and inactive disease. The risk of colorectal cancer in Crohns disease above the general population as high as 26.6,END,

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 标准材料 > 医药标准

本站为文档C TO C交易模式,本站只提供存储空间、用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。本站仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知淘文阁网,我们立即给予删除!客服QQ:136780468 微信:18945177775 电话:18904686070

工信部备案号:黑ICP备15003705号© 2020-2023 www.taowenge.com 淘文阁